Neurocrine Biosciences, Inc. (NBIX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 9.10B |
| Enterprise value | 8.38B |
| Trailing P/E | 60.42 |
| Forward P/E | 30.03 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 6.26 |
| Price/book (mrq) | 5.33 |
| Enterprise value/revenue | 5.63 |
| Enterprise value/EBITDA | 35.41 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.50 |
| 52-week change 3 | 2.53% |
| S&P500 52-week change 3 | -12.41% |
| 52-week high 3 | 129.29 |
| 52-week low 3 | 75.25 |
| 50-day moving average 3 | 104.25 |
| 200-day moving average 3 | 106.76 |
Share statistics
| Avg vol (3-month) 3 | 810.56k |
| Avg vol (10-day) 3 | 765.72k |
| Shares outstanding 5 | 96.59M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 95.3M |
| % held by insiders 1 | 0.97% |
| % held by institutions 1 | 96.19% |
| Shares short (27 Feb 2023) 4 | 2.54M |
| Short ratio (27 Feb 2023) 4 | 2.78 |
| Short % of float (27 Feb 2023) 4 | 3.02% |
| Short % of shares outstanding (27 Feb 2023) 4 | 2.63% |
| Shares short (prior month 30 Jan 2023) 4 | 2.61M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 28 Dec 1995 |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2022 |
| Most-recent quarter (mrq) | 30 Dec 2022 |
Profitability
| Profit margin | 10.38% |
| Operating margin (ttm) | 16.73% |
Management effectiveness
| Return on assets (ttm) | 7.01% |
| Return on equity (ttm) | 10.03% |
Income statement
| Revenue (ttm) | 1.49B |
| Revenue per share (ttm) | 15.54 |
| Quarterly revenue growth (yoy) | 32.10% |
| Gross profit (ttm) | 1B |
| EBITDA | 264.1M |
| Net income avi to common (ttm) | 154.5M |
| Diluted EPS (ttm) | 1.56 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 989.3M |
| Total cash per share (mrq) | 10.24 |
| Total debt (mrq) | 280.3M |
| Total debt/equity (mrq) | 16.41 |
| Current ratio (mrq) | 2.70 |
| Book value per share (mrq) | 17.70 |
Cash flow statement
| Operating cash flow (ttm) | 339.4M |
| Levered free cash flow (ttm) | 226.99M |
© 2023 Yahoo. All rights reserved.
